甲状腺癌伴肺转移患者总体生存率和癌症特异性生存率的Nomogram模型建立及验证
A Nomogram for Distinction and Potential Prediction of Lung Metastasis in Thyroid Cancer Patients
DOI: 10.12677/ACM.2021.118561, PDF,   
作者: 欧振飞, 齐 齐, 郭孝兹, 张雪娟*:青岛大学附属医院,山东 青岛
关键词: 甲状腺癌肺部转移临床预后NomogramThyroid Cancer Lung Metastasis Prognosis Nomogram
摘要: 目的:本研究的目的是开发一种有效的Nomogram来识别和预测甲状腺癌伴肺转移(thyroid cancer lung metastasis)患者,预测TCLM患者的总生存期(overall survival)和癌症特异性生存期(cancer specific survival),从而协助临床诊断和治疗。方法:本研究从SEER数据库共纳入544名已知甲状腺癌伴肺部转移的患者,并随机分配到训练组和验证组。采用Logistic回归筛选变量,并建立Nomogram模型。经过统计学分析我们发现年龄、组织学类型、肿瘤等级、肿瘤大小、肝转移、放疗、手术是构建Nomogram的重要变量。结果:用于识别和预测TCLM患者OS和CSS的Nomogram模型在校准曲线和受试者工作特征曲线(ROC)上得到了很好的检验。结论:本研究首先建立并验证TCLM患者预后相关的Nomogram模型,其中诊断年龄、组织学类型、肿瘤等级、肿瘤大小、肝转移、放疗、手术是影响该病预后的独立危险因素,帮助TCLM患者临床治疗及治疗后随访提供科学依据。
Abstract: Objective: The prognosis of thyroid cancer with lung metastasis is poor. Our aim is to develop a reliable tool to identify and predict lung metastasis (LM) in patients with thyroid cancer (TC), thereby assisting in clinical diagnosis and treatment. The aim of this study was to establish an effective Nomogram method for predicting overall survival (OS) and cancer specific survival (CSS) in TC patients with LM. Methods: A total of 544 patients with known distant metastatic status and epidemiological variables from the SEER database were enrolled and assigned randomly to training and validating groups in this study. Logistic regression was used to screen variables and a Nomogram was established. After multivariate logistic regression, age, histologic type, grade, tumor size, liver metastasis, radiotherapy and surgery were the important variables to construct the Nomogram. Results: The Nomogram used to identify and predict the OS and CSS in TCLM patients passed the calibration and validation steps. The calibration curve and receiver operating characteristic curves (ROC) indicated the good performance of the Nomogram. Conclusions: Our Nomogram is a reliable and robust tool for the identification and prediction of LM in TC patients, thus helping to better select medical examinations and optimize treatment in collaboration with medical oncologists and surgeons.
文章引用:欧振飞, 齐齐, 郭孝兹, 张雪娟. 甲状腺癌伴肺转移患者总体生存率和癌症特异性生存率的Nomogram模型建立及验证[J]. 临床医学进展, 2021, 11(8): 3820-3824. https://doi.org/10.12677/ACM.2021.118561

参考文献

[1] Siegel, R.L., Miller, K.D., Fuchs, H.E., et al. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. [Google Scholar] [CrossRef] [PubMed]
[2] Hundahl, S.A., Fleming, I.D., Fremgen, A.M., et al. (1998) A National Cancer Data Base Report on 53,856 Cases of Thyroid Carcinoma Treated in the U.S., 1985-1995. Cancer, 83, 2638-2648. [Google Scholar] [CrossRef
[3] Mazzaferri, E.L. and Kloos, R.T. (2001) Clinical Review 128: Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer. The Journal of Clinical Endocrinology and Metabolism, 86, 1447-1463. [Google Scholar] [CrossRef] [PubMed]
[4] Huang, I.C., Chou, F.F., Liu, R.T., et al. (2012) Long-Term Outcomes of Distant Metastasis from Differentiated Thyroid Carcinoma. Clinical Endocrinology, 76, 439-447. [Google Scholar] [CrossRef] [PubMed]
[5] Balachanddran, V.P., Gonen, M., Smith, J.J., et al. (2015) Nomograms in Oncology: More than Meets the Eye. The Lancet Oncology, 16, e173-e180. [Google Scholar] [CrossRef
[6] Song, H.J., Qiu, Z.L., Shen, C.T., et al. (2015) Pulmonary Metastases in Differentiated Thyroid Cancer: Efficacy of Radioiodine Therapy and Prognostic Factors. European Journal of Endocrinology, 173, 399-408. [Google Scholar] [CrossRef
[7] Lin, Z., Yan, S., Zhang, J., et al. (2018) A Nomogram for Distinction and Potential Prediction of Liver Metastasis in Breast Cancer Patients. Journal of Cancer, 9, 2098-2106. [Google Scholar] [CrossRef] [PubMed]
[8] Heagerty, P.J., Lumley, T. and Pepe, M.S. (2000) Time-Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker. Biometrics, 56, 337-344. [Google Scholar] [CrossRef
[9] Uka, K., Chayama, K., Aikata, H., et al. (2007) Clinical Features and Prognosis of Patients with Extrahepatic Metastases from Hepatocellular Carcinoma. World Journal of Gastroenterology, 13, 414-420. [Google Scholar] [CrossRef] [PubMed]
[10] Vickers, A.J. and Elkin, E.B. (2006) Decision Curve Analysis: A Novel Method for Evaluating Prediction Models. Medical Decision Making, 26, 565-574. [Google Scholar] [CrossRef
[11] Randle, R.W., Bushman, N.M., Orne, J., et al. (2017) Papillary Thyroid Cancer: The Good and Bad of the “Good Cancer”. Thyroid, 27, 902-907.
[12] Lin, J.D., Chao, T.C., Chou, S.C., et al. (2004) Papillary Thyroid Carcinomas with Lung Metastases. Thyroid, 14, 1091-1096. [Google Scholar] [CrossRef] [PubMed]
[13] Nixon, I.J., Whitcher, M.M., Palmer, F.L., et al. (2012) The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland. Thyroid, 22, 884-889. [Google Scholar] [CrossRef] [PubMed]
[14] Cho, S.W., Choi, H.S., Yeom, G.J., et al. (2014) Long-Term Prognosis of Differentiated Thyroid Cancer with Lung Metastasis in Korea and Its Prognostic Factors. Thyroid, 24, 277-286. [Google Scholar] [CrossRef] [PubMed]
[15] Chopra, S., Garg, A., Ballal, S., et al. (2015) Lung Metastases from Differentiated Thyroid Carcinoma: Prognostic Factors Related to Remission and Disease-Free Survival. Clinical Endocrinology, 82, 445-452. [Google Scholar] [CrossRef] [PubMed]
[16] Tang, J., Kong, D., Cui, Q.X., et al. (2018) Racial Disparities of Differentiated Thyroid Carcinoma: Clinical Behavior, Treatments, and Long-Term Outcomes. World Journal of Surgical Oncology, 16, 45. [Google Scholar] [CrossRef] [PubMed]
[17] Brierley, J., Tsang, R., Panzarella, T., et al. (2010) Prognostic Factors and the Effect of Treatment with Radioactive Iodine and External Beam Radiation on Patients with Differentiated Thyroid Cancer Seen at a Single Institution over 40 Years. Clinical Endocrinology, 63, 418-427. [Google Scholar] [CrossRef] [PubMed]
[18] Hu, P., Bai, J., Liu, M., et al. (2020) Trends of Incidence and Prognosis of Gastric Neuroendocrine Neoplasms: A Study Based on SEER and Our Multicenter Research. Gastric Cancer, 23, 591-599. [Google Scholar] [CrossRef] [PubMed]
[19] Huang, R., Sun, Z., Zheng, H., et al. (2019) Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database. Orthopaedic Surgery, 11, 801-810. [Google Scholar] [CrossRef] [PubMed]
[20] Ito, Y., Fukushima, M., Kihara, M., et al. (2012) Investigation of the Prognosis of Patients with Papillary Thyroid Carcinoma by Tumor Size. Endocrine Journal, 59, 457-464. [Google Scholar] [CrossRef
[21] Salvatori, M., Perotti, G., Rufini, V., et al. (2004) Solitary Liver Metastasis from Hürthle Cell Thyroid Cancer: A Case Report and Review of the Literature. Journal of Endocrinological Investigation, 27, 52-56. [Google Scholar] [CrossRef
[22] Song, H.J., Xue, Y.L., Qiu, Z.L., et al. (2012) Uncommon Metastases from Differentiated Thyroid Carcinoma. Hellenic Journal of Nuclear Medicine, 15, 233-240.
[23] Nakanishi, K., Kikumori, T., Miyajima, N., et al. (2018) Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma. Clinical Nuclear Medicine, 43, 482-485. [Google Scholar] [CrossRef
[24] Li, C., Wu, Q. and Sun, S.R. (2020) Radioactive Iodine Therapy in Patients with Thyroid Carcinoma with Distant Metastases: A SEER-Based Study. Cancer Control, 27, 1-9. [Google Scholar] [CrossRef] [PubMed]
[25] Haugen, B.R., Aleander, L.E.K., Bible, K.C., et al. (2015) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26, 1-133. [Google Scholar] [CrossRef] [PubMed]